Autophagy as a molecular target for cancer treatment

dc.contributor.author	Kocaturk, N.M.
dc.contributor.author	Akkoc, Y.
dc.contributor.author	Kig, C.
dc.contributor.author	Bayraktar, O.
dc.contributor.author	Gozuacik, D.
dc.contributor.author	Kutlu, O.
dc.date.accessioned	2021-12-21T08:40:53Z
dc.date.available	2021-12-21T08:40:53Z
dc.date.issued	2019
dc.identifier.uri	https://doi.org/10.1016/j.ejps.2019.04.011
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1241
dc.description.abstract	Autophagy is an evolutionarily conserved catabolic mechanism, by which eukaryotic cells recycle or degrades internal constituents through membrane-trafficking pathway. Thus, autophagy provides the cells with a sustainable source of biomolecules and energy
dc.description.sponsorship	This work was supported by Scientific and Technological Research Council of Turkey (TUBITAK)-1001 Grant number: 114Z836 . YA is supported by TUBITAK-BIDEB 2211 Scholarships for his PhD studies.
dc.title	Autophagy as a molecular target for cancer treatment
dc.relation.journal	European Journal of Pharmaceutical Sciences
dc.identifier.startpage	116
dc.identifier.endpage	137
dc.identifier.volume	134
dc.identifier.doi	10.1016/j.ejps.2019.04.011
dc.relation.volume	134